Angelalign TechnologyAGLFF -1.74%73 Market Cap is $1,659.6 Mil as of Jul. 08, 2026. GuruFocus rates AGLFF with a GF Score™ of 73/100 and a GF Value™ of $12.51 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Angelalign Technology ranks better than 85.81% on this metric.
Angelalign Technology's quarterly market cap
declined
from Dec. 2024 ($1,404.4 Mil) to Jun. 2025 ($1,234.6 Mil) but then
increased
from Jun. 2025 ($1,234.6 Mil) to Dec. 2025 ($1,477.2 Mil).
Angelalign Technology's annual market cap
increased
from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($1,404.4 Mil) and
increased
from Dec. 2024 ($1,404.4 Mil) to Dec. 2025 ($1,477.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Angelalign Technology's Enterprise Value for Today is $1,252.1 Mil.
Angelalign Technology (OTCPK:AGLFF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Angelalign Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Angelalign Technology Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Market Cap distribution charts can be found below:
* The bar in red indicates where Angelalign Technology's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Angelalign Technology's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology (AGLFF) has a Market Cap of $1,659.6 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Angelalign Technology and its competitors. According to the industry distribution chart, Angelalign Technology ranks #123 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 14.2%.
Is Angelalign Technology's Market Cap too high?
Angelalign Technology's current Market Cap is $1,659.6 Mil. The Medical Devices & Instruments industry median Market Cap is 121.11. Angelalign Technology's value of $1,659.6 Mil is 1270.3% above this industry median. Based on the distribution chart, Angelalign Technology ranks #123 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Angelalign Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #123 out of 867 companies for Market Cap. This places Angelalign Technology in the top 14% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.11. Angelalign Technology's value of $1,659.6 Mil is 1270.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current Market Cap of $1,659.6 Mil is 1270.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current Market Cap is $1,659.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (AGLFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.51, compared to a current price of $8.77 — trading 29.9% below its estimated fair value. The current Market Cap is $1,659.6 Mil and 1270.3% above the Medical Devices & Instruments industry median of 121.11. Angelalign Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Angelalign Technology (AGLFF), the current Market Cap is $1,659.6 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (AGLFF) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of $8.77 is trading 29.9% below its estimated GF Value™ of $12.51.
GuruFocus considers Angelalign Technology to be Significantly Undervalued.
Key valuation signals for AGLFF:
Market Cap: $1,659.6 Mil
GF Value™: $12.51 vs. price of $8.77 (29.9% below fair value)
Industry Position: 1270.3% above the Medical Devices & Instruments median (#123 of 867)
No single metric tells the full story. See the AGLFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
73GF Score
Get the complete analysis for AGLFF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGLFF has been successfully added to your 
